Scout | R21 Funding for Clinical Trial Readiness in Rare Diseases (Biomarkers and Outcomes)

This opportunity is no longer accepting applications.

nofo

R21 Funding for Clinical Trial Readiness in Rare Diseases (Biomarkers and Outcomes)

This funding opportunity supports early-stage clinical research activities that prepare rare diseases for upcoming clinical trials. Applicants may develop and validate biomarkers and clinical outcome measures, or better define how a rare disease presents and progresses to improve trial design. Note: the title indicates R21 clinical trial applications are not allowed, so projects must focus on …

Source

Agency: National Institutes of Health

Eligibility

government

industry:research

nonprofit

small_business

tribal

university

For profit organizations other than small businesses

Native American tribal governments (Federally recognized)

Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education

Private institutions of higher education

State governments

Keywords

clinical trial readiness

rare diseases

biomarkers

clinical outcomes

trial design

diagnostics

therapeutics

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers